FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to dermatology, pediatrics, allergology and immunology, and concerns a method for predicting the course of atopic dermatitis in children. Method essence is as follows: determine the concentration of fractalkine in the blood serum in a child with atopic dermatitis upon admission to the hospital, and at fractalkine concentration of 81 pg/ml to 150 pg/ml, predict a mild severity of atopic dermatitis, at fractalkine concentration of 151 pg/ml to 250 pg/ml, predict a moderate severity, and at a concentration of 251 pg/ml and above, predict a severe severity of atopic dermatitis.
EFFECT: claimed invention is directed to improving the accuracy of predicting the severity of atopic dermatitis in children.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF SEVERITY OF ATOPIC DERMATITIS IN CHILDREN | 2019 |
|
RU2711746C1 |
| METHOD OF PREDICTING DEGREE OF ATOPIC DERMATITIS IN CHILDREN | 2016 |
|
RU2630063C1 |
| METHOD FOR PREDICTING SEVERITY OF ATOPIC DERMATITIS IN CHILDREN WITH ACCOMPANYING INTESTINAL DYSBACTERIOSIS | 2018 |
|
RU2692803C1 |
| METHOD FOR DIAGNOSING THE SEVERITY OF EPSTEIN-BARR VIRUS-INDUCED ACUTE INFECTIOUS MONONUCLEOSIS IN CHILDREN | 2022 |
|
RU2797960C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE AND EVALUATION OF CLINICAL EFFECTIVENESS OF ATOPIC DERMATITIS TREATMENT | 2015 |
|
RU2603463C1 |
| METHOD FOR PREDICTION OF THE RISK OF DEVELOPMENT OF RECURRENT ATOPIC DERMATITIS | 2022 |
|
RU2794084C1 |
| METHOD FOR DETERMINING THE STAGE OF ATOPIC DERMATITIS | 2021 |
|
RU2772411C1 |
| METHOD FOR PREDICTING THE FLOW OF ATOPIC DERMATITIS | 2005 |
|
RU2310195C2 |
| METHOD FOR ASSESSING THE SEVERITY OF ATOPIC DERMATITIS IN CHILDREN BY OPTICAL COHERENCE TOMOGRAPHY | 2018 |
|
RU2692955C1 |
| METHOD FOR PREDICTION OF LEVEL OF EFFICIENCY OF REDUCTION OF MANIFESTATION SEVERITY OF ATOPIC DERMATITIS | 2011 |
|
RU2453851C1 |
